SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg3/21/2006 7:34:40 AM
   of 3044
 
Nitromed says CEO, CFO resigns
Tue Mar 21, 2006 7:28 AM ET

March 21 (Reuters) - Drugmaker NitroMed Inc. (NTMD.O: Quote, Profile, Research) said its chief executive officer and chief financial officer resigned on Tuesday.

The company in a statement said Michael Loberg resigned as president, CEO and director, while Lawrence Bloch resigned as CFO and chief business officer.

The company did not provide any reason for the resignations, but said Chairman Argeris Karabelas has been named interim CEO and Kenneth Bate appointed CFO and chief operating officer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext